Patents by Inventor Heather Barbara Streeter

Heather Barbara Streeter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide Selection Method
    Publication number: 20180311328
    Abstract: There is provided a method for selecting a tolerogenic peptide by selecting a peptide which is capable of binding to an MHC class I or H molecule without further processing. There is also provided a peptide selected by such a method and its use in a pharmaceutical composition and a method to treat and/or prevent a disease.
    Type: Application
    Filed: March 20, 2018
    Publication date: November 1, 2018
    Inventors: David Cameron Wraith, Stephen Mark Anderton, Graziella Mazza, Mary Ponsford, Heather Barbara Streeter
  • Methods of using myelin basic protein peptide compositions
    Patent number: 9381234
    Abstract: The present invention relates to a composition which comprises the following myelin basic protein peptides: MBP 30-44; MBP 83-99; MBP 131-145; and MBP 140-154. The composition may be used to treat a disease, in particular multiple sclerosis and/or optical neuritis and the invention also relates to such uses and methods.
    Type: Grant
    Filed: December 6, 2013
    Date of Patent: July 5, 2016
    Assignee: APITOPE TECHNOLOGY (BRISTOL) LIMITED
    Inventors: David Wraith, Heather Barbara Streeter
  • Peptide composition
    Patent number: 8961986
    Abstract: There is provided a method for selecting a tolerogenic peptide by selecting a peptide which is capable of binding to an MHC class I or II molecule without further processing. There is also provided a peptide selected by such a method and its use in a pharmaceutical composition and a method to treat and/or prevent a disease. The present invention also relates to a composition which comprises the following myelin basic protein peptides: MBP 30-44; MBP 83-99; MBP 131-145; and MBP 140-154. The composition may be used to treat a disease, in particular multiple sclerosis and/or optical neuritis and the invention also relates to such uses and methods.
    Type: Grant
    Filed: December 6, 2012
    Date of Patent: February 24, 2015
    Assignee: Apitope Technology (Bristol) Limited
    Inventors: David Wraith, Heather Barbara Streeter
  • COMPOSITION
    Publication number: 20140161832
    Abstract: The present invention relates to a composition which comprises the following myelin basic protein peptides: MBP 30-44; MBP 83-99; MBP 131-145; and MBP 140-154. The composition may be used to treat a disease, in particular multiple sclerosis and/or optical neuritis and the invention also relates to such uses and methods.
    Type: Application
    Filed: December 6, 2013
    Publication date: June 12, 2014
    Applicant: APITOPE TECHNOLOGY (BRISTOL) LIMITED
    Inventors: David Wraith, Heather Barbara Streeter
  • Peptide composition
    Patent number: 8343500
    Abstract: There is provided a method for selecting a tolerogenic peptide by selecting a peptide which is capable of binding to an MHC class I or II molecule without further processing. There is also provided a peptide selected by such a method and its use in a pharmaceutical composition and a method to treat and/or prevent a disease. The present invention also relates to a composition which comprises the following myelin basic protein (MBP) peptides: MBP 30-44; MBP 83-99; MBP 131-145; and MBP 140-154. The composition may be used to treat a disease, in particular multiple sclerosis and/or optical neuritis and the invention also relates to such uses and methods.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: January 1, 2013
    Assignee: Apitope Technology (Bristol) Limited
    Inventors: David Cameron Wraith, Heather Barbara Streeter
  • Composition
    Publication number: 20100286054
    Abstract: The present invention relates to a composition which comprises the following myelin basic protein peptides: MBP 30-44, MBP 83-99, MBP 131-145, and MBP 140-154. The composition may be used to treat a disease, in particular multiple sclerosis and/or optical neuritis and the invention also relates to such uses and methods.
    Type: Application
    Filed: October 30, 2008
    Publication date: November 11, 2010
    Applicant: APITOPE TECHNOLOGY (BRISTOL) LIMITED
    Inventors: David Wraith, Heather Barbara Streeter
  • Peptide composition
    Publication number: 20080200368
    Abstract: There is provided a method for selecting a tolerogenic peptide by selecting a peptide which is capable of binding to an MHC class I or II molecule without further processing. There is also provided a peptide selected by such a method and its use in a pharmaceutical composition and a method to treat and/or prevent a disease. The present invention also relates to a composition which comprises the following myelin basic protein (MBP) peptides: MBP 30-44; MBP 83-99; MBP 131-145; and MBP 140-154. The composition may be used to treat a disease, in particular multiple sclerosis and/or optical neuritis and the invention also relates to such uses and methods.
    Type: Application
    Filed: October 31, 2007
    Publication date: August 21, 2008
    Applicant: Apitope Technology (Bristol) Ltd.
    Inventors: David Cameron Wraith, Heather Barbara Streeter
  • Tolerogenic peptides from myelin basic protein
    Patent number: 7071297
    Abstract: There is provided a peptide that is capable of binding to an MHC class I or II molecule without further processing (i.e., an apitope), which comprises a portion of the region 131-158 of myelin basic protein. In particular, there is provided an apitope which is selected from the following myelin basic protein peptides: 134-148, 135-149, 136-150, 137-151, 138-152, 139-153, 140-154. There is also provided the use of such a peptide in a pharmaceutical composition and a method to treat and/or prevent a disease using such a peptide.
    Type: Grant
    Filed: July 27, 2004
    Date of Patent: July 4, 2006
    Assignee: Apitope Technology (Bristol) Limited
    Inventors: David Cameron Wraith, Heather Barbara Streeter, Mary Ponsford, Graziella Mazza
  • Peptide selection method
    Publication number: 20030191063
    Abstract: There is provided a method for selecting a tolerogenic peptide by selecting a peptide which is capable of binding to an MHC class I or II molecule without further processing. There is also provided a peptide selected by such a method and its use in a pharmaceutical composition and a method to treat and/or prevent a disease.
    Type: Application
    Filed: June 5, 2003
    Publication date: October 9, 2003
    Inventors: David Cameron Wraith, Stephen Mark Anderton, Graziella Mazza, Mary Ponsford, Heather Barbara Streeter